Evidence map›Paper›PMID 35185841›Full record

ArticleFrontiers in microbiology2022

Identification of Antimicrobial Compounds in Two

Fernando Santos-Beneit, Ana Ceniceros, Athanasios Nikolaou, José A Salas, Jorge Gutierrez-Merino

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antifungal and Immunomodulatory Activities of Brazilian SavannahPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. EndophyticFrontiers in microbiology · 2025
    Article
  7. Review
  8. Genomic and Untargeted Metabolomic Analysis of Secondary Metabolites in theJournal of agricultural and food chemistry · 2024
    Article
  9. Genomic Characterization ofMicroorganisms · 2024
    Article
  10. Review
  11. Metabolic and genomic analysis deciphering biocontrol potential of endophytic Streptomyces albus RC2 against crop pathogenic fungi.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Characterization ofMicroorganisms · 2023
    Article
  17. Beehives possess their own distinct microbiomes.Environmental microbiome · 2023
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Fernando Santos-BeneitDepartment of Chemical Engineering and Environmental Technology, School of Industrial Engineering, University of Valladolid, Valladolid, Spain.
Ana CenicerosDepartamento de Biología Funcional, Universidad de Oviedo, Oviedo, Spain.
Athanasios NikolaouSchool of Biosciences and Medicine, University of Surrey, Guildford, United Kingdom.
José A SalasDepartamento de Biología Funcional, Universidad de Oviedo, Oviedo, Spain.
Jorge Gutierrez-MerinoSchool of Biosciences and Medicine, University of Surrey, Guildford, United Kingdom.
Universidad de Oviedo · ESUniversity of Surrey · GBUniversidad de Valladolid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization warns that the alarming increase in antibiotic resistant bacteria will lead to 2.7 million deaths annually due to the lack of effective antibiotic therapies. Clearly, there is an urgent need for short-term alternatives that help to alleviate these alarming figures. In this respect, the scientific community is exploring neglected ecological niches from which the prototypical antibiotic-producing bacteria Streptomycetes are expected to be present. Recent studies have reported that honeybees and their products carry

Indexed as

antifungalantimycinbeehivecandicidinhoneypollenStreptomycesundecylprodigiosin

Identifiers

PMID35185841
PMCPMC8851239
OpenAlexW4210497151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.